- Country: Italy
- Summary: In-Service Supply of a New and Latest Generation System for the Determination of Galactomannan Antigen and other Analytes of not Particularly Frequent Infectious Diseases
- ITT Ref No: 128602927
- Deadline: 01 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 459400.00
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINIn-Service Supply of a New and Latest Generation System for the Determination of Galactomannan Antigen and other Analytes of not Particularly Frequent Infectious Diseases - Italy Tender
The ASL 3 - PESCARA, a Government sector organization in Italy, has announced a new tender for In-Service Supply of a New and Latest Generation System for the Determination of Galactomannan Antigen and other Analytes of not Particularly Frequent Infectious Diseases. This tender is published on ItalyTenders under ITT Ref No: 128602927 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-01.
The estimated tender value is EUR 459400.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
